Current
Research in
Ophthalmology >>

A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects with Rhegmatogenous Retinal Detachment

Principal Investigator

Richard Rosen, M.D.

Enrollment Status 

Completed

Objective 

The purpose of this research study is to determine if administration of denufosol intravitreal injection, an investigational drug not approved by the FDA, is well-tolerated and more efficacious than placebo in stimulating subretinal fluid reabsorption and retinal reattachment without surgical intervention in subjects presenting with rhegmatogenous retinal detachment (RRD).

Study results are currently being analyzed. Please visit this webpage next month for the study update. For more information: ClinicalTrials.gov

Home > Current Research > Clinical Trials in Ophthalmology > Results > A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects with Rhegmatogenous Retinal Detachment